- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 19/06 - Antigout agents, e.g. antihyperuricemic or uricosuric agents
Patent holdings for IPC class A61P 19/06
Total number of patents in this class: 825
10-year publication summary
|
33
|
23
|
28
|
40
|
64
|
60
|
53
|
77
|
61
|
40
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Teijin Pharma Limited | 260 |
20 |
| Kissei Pharmaceutical Co., Ltd. | 183 |
18 |
| Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | 32 |
17 |
| Nippon Chemiphar Co., Ltd. | 227 |
14 |
| Takeda Pharmaceutical Company Limited | 2703 |
11 |
| Banyu Pharmaceutical Co., Ltd. | 62 |
11 |
| LG Chem, Ltd. | 17636 |
10 |
| Daiichi Sankyo Company, Limited | 1881 |
10 |
| Japan Tobacco Inc. | 3600 |
9 |
| Horizon Therapeutics USA, Inc. | 56 |
9 |
| China Pharmaceutical University | 308 |
8 |
| Hinova Pharmaceuticals Inc. | 99 |
8 |
| Pfizer Inc. | 3367 |
7 |
| Jiangsu Hengrui Medicine Co., Ltd. | 708 |
7 |
| Ardea Biosciences, Inc. | 72 |
6 |
| Xiangbei Welman Pharmaceutical Co., Ltd. | 33 |
6 |
| Hangzhou Grand Biologic Pharmaceutical Inc. | 14 |
6 |
| Proabtech Co., Ltd. | 9 |
6 |
| Bristol-myers Squibb Company | 4872 |
5 |
| Astellas Pharma Inc. | 1083 |
5 |
| Other owners | 632 |